FAM
TXG icon

Fred Alger Management’s 10x Genomics TXG Stock Holding History

Fred Alger Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.13M Buy
212,125
+100,246
+90% +$2.63M 0.03% 193
2026
Q1 		$2.38M Buy
111,879
+10,196
+10% +$204K 0.01% 301
2025
Q4 		$1.66M Buy
101,683
+36,300
+56% +$548K 0.01% 325
2025
Q3 		$764K Sell
65,383
-78,030
-54% -$1.02M ﹤0.01% 380
2025
Q2 		$1.66M Buy
143,413
+77,983
+119% +$711K 0.01% 323
2025
Q1 		$571K Hold
65,430
– – ﹤0.01% 350
2024
Q4 		$940K Sell
65,430
-42
-0.1% -$663 ﹤0.01% 366
2024
Q3 		$1.48M Sell
65,472
-501
-0.8% -$10.4K 0.01% 341
2024
Q2 		$1.28M Sell
65,973
-379,594
-85% -$9.94M 0.01% 348
2024
Q1 		$16.7M Buy
445,567
+40,384
+10% +$1.77M 0.08% 162
2023
Q4 		$22.7M Buy
+405,183
New +$17.6M 0.12% 133
2023
Q2 		– Sell
-8,820
Closed -$492K – 571
2023
Q1 		$492K Buy
+8,820
New +$412K ﹤0.01% 402
2022
Q2 		– Sell
-328,561
Closed -$25M – 549
2022
Q1 		$25M Buy
328,561
+248,537
+311% +$21.7M 0.08% 174
2021
Q4 		$11.9M Sell
80,024
-76,023
-49% -$11.6M 0.03% 232
2021
Q3 		$22.7M Buy
156,047
+16,610
+12% +$2.85M 0.05% 196
2021
Q2 		$27.3M Sell
139,437
-27,875
-17% -$5.04M 0.06% 195
2021
Q1 		$30.3M Buy
167,312
+106,728
+176% +$18.4M 0.08% 187
2020
Q4 		$8.58M Buy
60,584
+27,046
+81% +$3.92M 0.02% 244
2020
Q3 		$4.18M Buy
33,538
+9,123
+37% +$958K 0.01% 255
2020
Q2 		$2.18M Sell
24,415
-12,002
-33% -$935K 0.01% 300
2020
Q1 		$2.27M Buy
36,417
+1,714
+5% +$134K 0.01% 262
2019
Q4 		$2.65M Buy
34,703
+28,703
+478% +$1.73M 0.01% 278
2019
Q3 		$302K Buy
+6,000
New +$332K ﹤0.01% 391

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fred Alger Management's TXG Position: Q2 2026 in Review

Fred Alger Management increased its 10x Genomics (TXG) stake by 90% in Q2 2026, buying an estimated $2.63M and bringing the position to 212,125 shares worth $8.13M. The position accounts for 0.03% of the portfolio, ranked #193.

Fred Alger Management first reported a position in TXG in Q3 2019 and has held it in 23 quarters since. The position peaked at $30.3M in Q1 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Fred Alger Management held 212,125 shares of 10x Genomics worth $8.13M as of Q2 2026.
  • Fred Alger Management bought 100,246 10x Genomics shares in Q2 2026, an estimated $2.63M.
  • 10x Genomics made up 0.03% of Fred Alger Management's portfolio in Q2 2026, its #193 holding.
  • Fred Alger Management first reported a position in 10x Genomics in Q3 2019 and has held it in 23 quarters since.
  • Fred Alger Management's 10x Genomics position peaked at $30.3M in Q1 2021.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.